Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Angulo

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
The American Journal of Gastroenterology|June 3, 2005
Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitisAndrea A Gossard, Paul Angulo, Keith D Lindor
Seminars in Liver Disease|May 15, 2015
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implicationsPaul Angulo, Mariana Verdelho Machado, Anna Mae Diehl
The American Journal of Gastroenterology|July 6, 2004
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver diseaseLeon A Adams, Keith D Lindor, Paul Angulo
Hepatology (Baltimore, Md.)|November 10, 2007
Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitisPhunchai Charatcharoenwitthaya, Paul Angulo, Felicity B Enders, et al.
Journal of Hepatology|January 5, 2005
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesLeon A Adams, Schuyler Sanderson, Keith D Lindor, et al.
Journal of Clinical Gastroenterology|July 19, 2003
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosisJoanna L Siegel, Roberta Jorgensen, Paul Angulo, et al.
The American Journal of Gastroenterology|October 19, 2002
Results of long-term ursodiol treatment for patients with primary biliary cirrhosisRoberta Jorgensen, Paul Angulo, E Rolland Dickson, et al.
Hepatology (Baltimore, Md.)|April 2, 2004
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunctionLeon A Adams, Ariel Feldstein, Keith D Lindor, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 6, 2015
Nonalcoholic fatty liver disease: a precursor of the metabolic syndromeAmedeo Lonardo, Stefano Ballestri, Giulio Marchesini, et al.
Digestive Diseases and Sciences|October 18, 2007
Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot studyPaul Angulo, Roberta A Jorgensen, Kris V Kowdley, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
The American Journal of Gastroenterology|June 3, 2005
Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitisAndrea A Gossard, Paul Angulo, Keith D Lindor
Seminars in Liver Disease|May 15, 2015
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implicationsPaul Angulo, Mariana Verdelho Machado, Anna Mae Diehl
The American Journal of Gastroenterology|July 6, 2004
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver diseaseLeon A Adams, Keith D Lindor, Paul Angulo
Hepatology (Baltimore, Md.)|November 10, 2007
Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitisPhunchai Charatcharoenwitthaya, Paul Angulo, Felicity B Enders, et al.
Journal of Hepatology|January 5, 2005
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesLeon A Adams, Schuyler Sanderson, Keith D Lindor, et al.
Journal of Clinical Gastroenterology|July 19, 2003
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosisJoanna L Siegel, Roberta Jorgensen, Paul Angulo, et al.
The American Journal of Gastroenterology|October 19, 2002
Results of long-term ursodiol treatment for patients with primary biliary cirrhosisRoberta Jorgensen, Paul Angulo, E Rolland Dickson, et al.
Hepatology (Baltimore, Md.)|April 2, 2004
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunctionLeon A Adams, Ariel Feldstein, Keith D Lindor, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 6, 2015
Nonalcoholic fatty liver disease: a precursor of the metabolic syndromeAmedeo Lonardo, Stefano Ballestri, Giulio Marchesini, et al.
Digestive Diseases and Sciences|October 18, 2007
Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot studyPaul Angulo, Roberta A Jorgensen, Kris V Kowdley, et al.
Pageof 12